Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
20. Mai 2024 06:35 ET
|
Shah Capital
Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi Stresses Significant Value Still Remains to Be Unlocked at Novavax Still Believes Novavax Would Benefit from Stockholder...
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
06. Mai 2024 06:22 ET
|
Shah Capital
Highlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value ...
Shah Capital nominates two highly qualified independent director candidates for Novavax
15. April 2024 06:00 ET
|
Shah Capital
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of...
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
21. Mai 2020 06:30 ET
|
Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...
UPDATE - Shah Capital Asks Gulfport to Reduce 2020 Capex by Over 25%
06. September 2019 14:30 ET
|
Shah Capital
OKLAHOMA CITY, Sept. 06, 2019 (GLOBE NEWSWIRE) -- September 6, 2019 Gulfport Energy Corporation3001 Quail Springs Pkwy. Oklahoma City, Oklahoma 73134 To Gulfport Board of Directors, Shah...
Shah Capital Asks Gulfport to Reduce 2020 Capex by Over 25%
06. September 2019 10:28 ET
|
Shah Capital
OKLAHOMA CITY, Sept. 06, 2019 (GLOBE NEWSWIRE) -- September 6, 2019 Gulfport Energy Corporation3001 Quail Springs Pkwy. Oklahoma City, Oklahoma 73134 To Gulfport Board of Directors, ...